The efficacy of probiotics on virus titres and antibody production in virus diseases: A systematic review on recent evidence for COVID-19 treatment
2021
Mirashrafi, Shahrzad | Moravejolahkami, Amir Reza | Balouch Zehi, Zakiyeh | Hojjati Kermani, Mohammad Ali | Bahreini-Esfahani, Nimah | Haratian, Mohsen | Ganjali Dashti, Marjan | Pourhossein, Meraj
There are some studies indicating the effects of probiotic-containing foods or supplements on viral diseases. We aimed to conduct a rapid review of probiotics with specific emphasis on their potential for early administration in patients at greater risk of SARS-CoV-2 infection. We searched on PubMed, EMBASE, Google Scholar, Science Direct, Scopus and Web of Science up to February 2021 to identify interventional and observational studies documenting the effects of probiotics strains on interleukins, virus titers, and antibody production with a focus on probiotic-containing foods (PROSPERO Registration ID. CRD42020181453) From a total of 163 records, 21 studies were classified into three domains based on the efficacy of probiotics on 1) the level of interleukins (n = 7), 2) virus titers (n = 2), and 3) interferon (IFN) and antibody production (n = 12). The suppuration of pro-inflammatory interleukins and type I INF production seemed to be the main anti-viral effect of probiotics. Nine studies also indicated the beneficial effects of probiotics and fermented foods on viral diseases. Based on evidence, some probiotic strains may be useful in viral infections; randomized trials are needed to confirm these findings.
显示更多 [+] 显示较少 [-]